Bergan Kdv Wealth Management, LLC Veracyte, Inc. Transaction History
Bergan Kdv Wealth Management, LLC
- $999 Million
- Q2 2023
A detailed history of Bergan Kdv Wealth Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 1,500 shares of VCYT stock, worth $31,994. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500Holding current value
$31,994% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
257Shares Held
81.7MCall Options Held
43KPut Options Held
82K-
Vanguard Group Inc Valley Forge, PA7.38MShares$158 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.37MShares$157 Million0.03% of portfolio
-
Black Rock Inc. New York, NY7.21MShares$154 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.04MShares$150 Million1.11% of portfolio
-
State Street Corp Boston, MA4.33MShares$92.3 Million0.0% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.53B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...